Friday, November 6, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Edgewell Stock Plummets on Sun Care Weakness, But Long-Term Hopes Remain

Felix Baarz by Felix Baarz
August 30, 2025
in Analysis, Automotive & E-Mobility, Banking & Insurance, Consumer & Luxury, Dividends, Dow Jones, Earnings, Energy & Oil, Ethereum & Altcoins, Healthcare, Hydrogen, Stocks, Tech & Software, Turnaround
0
Edgewell Personal Care Stock
0
SHARES
286
VIEWS
Share on FacebookShare on Twitter

A disappointing summer for sun care sales has triggered a significant downturn for consumer goods conglomerate Edgewell Personal Care. The company, known for its Banana Boat and Wilkinson Sword brands, is facing investor skepticism after reporting dismal quarterly results that sent its shares tumbling. However, some strategic moves suggest potential recovery for patient investors.

Q3 Fiscal 2025 Results Spark Sell-Off

Edgewell’s third fiscal quarter proved challenging, with the company falling short of revenue expectations. It posted sales of $627.2 million, significantly below the anticipated $658.5 million and representing a 3.2% decrease year-over-year. The situation appeared more concerning when examining organic revenue, which declined by 4.2%.

The company’s adjusted earnings per share also disappointed, dropping to $0.92 from $1.22 in the comparable period. This fell well below the $1.01 per share that market analysts had projected. Management attributed the weak performance primarily to poor sun care product sales across North America and parts of Latin America due to unfavorable weather conditions. Consequently, net income plummeted 40.6% to $29.1 million.

Analyst Community Responds With Downgrades

Financial institutions quickly adjusted their outlooks for Edgewell following the earnings release:

  • UBS maintained its neutral rating but reduced its price target from $28 to $21
  • Barclays lowered its target price from $26 to $22
  • Morgan Stanley upgraded the stock to “Equal Weight” while simultaneously cutting its target from $26 to $23

A single positive note emerged from Canaccord Genuity, which maintained its buy recommendation despite trimming its price target from $35 to $32. The firm characterized the stock as oversold in the current market.

Should investors sell immediately? Or is it worth buying Edgewell Personal Care?

Institutional Investors Show Diverging Strategies

The reaction from major investment firms presented a mixed picture during the market turmoil. While retail investors engaged in widespread selling, several institutional players actually increased their holdings:

  • Charles Schwab Investment Management boosted its position by 7.8% to 881,101 shares
  • Public Sector Pension Investment Board expanded its stake by 40.5% to 170,649 shares
  • Nuveen LLC established a new position comprising 113,237 shares

This bullish sentiment wasn’t universal, however. Gabelli Funds reduced its exposure by 14.7%, highlighting the divided opinions on Edgewell’s recovery prospects.

Dividend Commitment Provides Stability

Despite the disappointing quarterly performance, Edgewell reaffirmed its commitment to shareholder returns. The company confirmed its quarterly dividend of $0.15 per share, payable in October. At the current share price, this distribution represents an attractive dividend yield of approximately 2.6%.

The coming quarters will determine whether the company’s sun care troubles were merely weather-related or indicative of deeper structural challenges. The consistent dividend policy may help maintain investor confidence as Edgewell navigates this difficult period.

Ad

Edgewell Personal Care Stock: Buy or Sell?! New Edgewell Personal Care Analysis from November 5 delivers the answer:

The latest Edgewell Personal Care figures speak for themselves: Urgent action needed for Edgewell Personal Care investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 5.

Edgewell Personal Care: Buy or sell? Read more here...

Tags: Edgewell Personal Care
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Shell Stock
Commodities

Shell’s Gas Ambitions Meet Buyback Discipline as LNG Canada Talks Take Shape

September 25, 2026
Siemens Energy Stock
Energy & Oil

Siemens Energy: Nuclear Ambitions Meet Chart Warnings as CEO Urges Crisis Preparedness

September 7, 2026
Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
Next Post
Zedge Stock

Zedge Stock Plunge: Was This Decline Predictable?

Ormat Stock

Ormat Technologies Powers Ahead with Strategic Geothermal Expansion

Oric Pharmaceuticals Inc Stock

Oric Pharmaceuticals Positions for Critical Growth Phase with Robust Pipeline and Funding

Recommended

indiemiconductor Stock

Indie Semiconductor Shares Face Technical Headwinds

1 year ago
BioNTech Stock

BioNTech Secures CureVac Acquisition in Landmark mRNA Deal

11 months ago
Food Retailers Market Capitalization

Victorias Secret Reports Strong Earnings Growth and Strategic Initiatives for Future Success

3 years ago

CNH Industrials Financial Report for Q4 2023 Meeting Expectations and Predicting a Slowdown in 2024

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

Pharma Pays for the Rotation While Crypto Hunts for a Floor

Tech Loses $1 Trillion, but the Rest of the Market Holds

Alphabet’s Cloud Doubles, Its Cash Turns Negative, the Stock Sinks

Margins Over Stories: Who Delivers Before the Fed and Big Tech

UPS and Coca-Cola Raise Guidance by Charging More, Not Selling More

Trending

Fastly Stock
Newsletter

Maersk Lifts Guidance a Third Time, and the Stock Still Sinks

by Stephanie Dugan
November 5, 2026
0

Dear readers, Raised guidance was supposed to be the safe harbor of earnings season. Maersk has tested...

AMD Stock

Democrats Win, and the Market Sorts Solar From Musk and Defense

November 4, 2026
Apple Stock

Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

November 3, 2026
Lumentum Stock

Profits Show Up Beyond AI, Even When Deal Premiums Don’t

November 2, 2026
Bitcoin Stock

Pharma Pays for the Rotation While Crypto Hunts for a Floor

October 31, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Maersk Lifts Guidance a Third Time, and the Stock Still Sinks
  • Democrats Win, and the Market Sorts Solar From Musk and Defense
  • Good Quarters, Heavy Selling: Cash Flow Beats Growth on Election Day

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com